Robert E. Gagnon, Chief Financial Officer at Opus Genetics, Inc. (IRD), sold 7,842 shares at $5.18 ($41K) on 2026-04-23, disclosed to the SEC on 2026-04-27.
Open-market sale of $41k IRD by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VSTM | SELL | 2025-12-18 | $3K | — | Filing → |
| VSTM | SELL | 2025-09-18 | $3K | — | Filing → |
| VSTM | SELL | 2025-06-20 | $2K | — | Filing → |